RELMADA THERAPEUTICS, INC. (RLMD) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2025)

-$57.4M

Total Assets (FY2025)

$94.0M

Total Equity (FY2025)

$86.5M

Cash Flows from Operating Activities (FY2025)

-$45.8M

Source: RELMADA THERAPEUTICS, INC. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.